PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.
First Affiliated Hospital of Wenzhou Medical University
First Affiliated Hospital of Wenzhou Medical University
Centre Hospitalier Universitaire, Amiens
National Institutes of Health Clinical Center (CC)
Lokman Hekim University
Aarhus University Hospital
Pfizer
Pfizer
Brigham and Women's Hospital
Malatya Turgut Ozal University
Mayo Clinic
Pfizer
Centre Hospitalier Universitaire de Nīmes
Yale University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Institut du Cancer de Montpellier - Val d'Aurelle
National Cancer Institute (NCI)
Assistance Publique Hopitaux De Marseille
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
Ipsen
Mayo Clinic
Spanish Oncology Genito-Urinary Group
IRCCS San Raffaele
Stanford University
Taipei Medical University
Azienda Ospedaliera Universitaria Integrata Verona
The University of Texas Health Science Center at San Antonio
Ordu University
Pfizer
Ohio State University Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Central Hospital, Nancy, France
Aesculap AG
University Hospital, Toulouse
Janssen Pharmaceutical K.K.
National Institutes of Health Clinical Center (CC)
Centre Hospitalier Universitaire de Besancon
Pfizer
City of Hope Medical Center
Centre Hospitalier Universitaire de Nīmes
H. Lee Moffitt Cancer Center and Research Institute
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Centre Hospitalier Universitaire de Nīmes
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
UNC Lineberger Comprehensive Cancer Center
Ege University
Centre Hospitalier Universitaire de Nīmes
Assistance Publique - Hôpitaux de Paris
Bristol-Myers Squibb